TW200626080A - Food compositions comprising valine for improving lipid metabolism - Google Patents

Food compositions comprising valine for improving lipid metabolism

Info

Publication number
TW200626080A
TW200626080A TW095109909A TW95109909A TW200626080A TW 200626080 A TW200626080 A TW 200626080A TW 095109909 A TW095109909 A TW 095109909A TW 95109909 A TW95109909 A TW 95109909A TW 200626080 A TW200626080 A TW 200626080A
Authority
TW
Taiwan
Prior art keywords
lipid metabolism
improving lipid
valine
compositions
food compositions
Prior art date
Application number
TW095109909A
Other languages
English (en)
Inventor
Susumu Satomi
Hideyuki Doi
Hiromichi Komatsu
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of TW200626080A publication Critical patent/TW200626080A/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW095109909A 2000-10-13 2001-10-12 Food compositions comprising valine for improving lipid metabolism TW200626080A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000312862 2000-10-13

Publications (1)

Publication Number Publication Date
TW200626080A true TW200626080A (en) 2006-08-01

Family

ID=18792372

Family Applications (2)

Application Number Title Priority Date Filing Date
TW090125293A TWI266614B (en) 2000-10-13 2001-10-12 Compositions comprising valine for improving lipid metabolism
TW095109909A TW200626080A (en) 2000-10-13 2001-10-12 Food compositions comprising valine for improving lipid metabolism

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TW090125293A TWI266614B (en) 2000-10-13 2001-10-12 Compositions comprising valine for improving lipid metabolism

Country Status (10)

Country Link
US (1) US7238727B2 (zh)
EP (1) EP1325743A4 (zh)
JP (1) JPWO2002030418A1 (zh)
KR (1) KR20030036898A (zh)
CN (1) CN1278677C (zh)
AU (2) AU2001294245B2 (zh)
CA (1) CA2425773A1 (zh)
HK (1) HK1059052A1 (zh)
TW (2) TWI266614B (zh)
WO (1) WO2002030418A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200518768A (en) * 2003-11-17 2005-06-16 Pepgen Corp Methods for treatment of obesity and for promotion of weight loss
EP1832284A4 (en) * 2004-12-28 2008-07-30 Ajinomoto Kk INDUCER OR SECRETAGOGUE OF ADIPONECTIN
WO2007049818A1 (ja) * 2005-10-27 2007-05-03 Ajinomoto Co., Inc. 抗脂肪肝、抗肥満及び抗高脂血症用組成物
WO2007069744A1 (ja) * 2005-12-16 2007-06-21 Ajinomoto Co., Inc. メタボリックシンドローム予防・改善用組成物
PT2440232T (pt) * 2009-06-12 2018-03-23 Wisconsin Alumni Res Found Formulações nutricionais à base de glicomacropeptídeo para o tratamento dietético da fenilcetonúria e de outras doenças metabólicas
EP2741757B1 (en) 2011-09-11 2018-05-16 Minovia Therapeutics Ltd. Compositions of functional mitochondria and uses thereof
CN107296264A (zh) * 2016-04-14 2017-10-27 高安友 预防及治疗高血脂、脂肪肝的大鲵油脂食品及其制备方法
JP7458368B2 (ja) 2018-07-22 2024-03-29 ミノヴィア セラピューティクス リミテッド 筋疾患のミトコンドリア増強療法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4042687A (en) * 1975-11-24 1977-08-16 Control Drug, Inc. Method of treating obesity by the oral administration of a predigested protein composition
US4833128A (en) * 1984-12-28 1989-05-23 Neil Solomon Dietary supplement
WO1988001872A1 (en) * 1986-09-10 1988-03-24 Dudrick Medical Research Fund I, Ltd. Method and substrate composition for treating atherosclerosis
US5032608A (en) * 1986-09-10 1991-07-16 Dudrick Stanley J Method and substrate composition for treating atherosclerosis
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
US5132113A (en) 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids
US5242697A (en) * 1990-10-26 1993-09-07 Maurizio Luca Method of preparing nutrified food products
AU655780B2 (en) 1990-10-30 1995-01-12 Clintec Nutrition Company A method and composition for the protection of a metabolic recovery of ischemic cardiac tissue
EP0605742A4 (en) 1992-06-26 1996-01-03 Nonna Dmitrievna Kislyakova Agent with adaptogenic activity.
JPH0624977A (ja) * 1992-07-10 1994-02-01 Rikagaku Kenkyusho 抗肥満剤及び抗高脂血症剤
JP4009682B2 (ja) * 1993-05-28 2007-11-21 独立行政法人理化学研究所 アドレナリン及びノルアドレナリン分泌促進組成物
IT1274783B (it) 1994-12-15 1997-07-24 Antonio Picarelli Preparato per il trattamento dell'obesita'
DE19528388A1 (de) 1995-08-02 1997-02-06 Hans Peter Prof Dr Med Zenner Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
JP4484254B2 (ja) * 1995-12-06 2010-06-16 佐々木化学工業株式会社 アミノ酸組成剤
WO1997025883A1 (de) 1996-01-17 1997-07-24 Friedrich Kisters Aminosäuren-präparat zur haarwuchsförderung
TW473387B (en) 1997-09-30 2002-01-21 Chugai Pharmaceutical Co Ltd Pharmaceutical or food compositions for treating hepatic diseases or improving liver functions
US6149924A (en) 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin

Also Published As

Publication number Publication date
TWI266614B (en) 2006-11-21
WO2002030418A1 (fr) 2002-04-18
AU2001294245B2 (en) 2006-09-21
US7238727B2 (en) 2007-07-03
JPWO2002030418A1 (ja) 2004-02-19
KR20030036898A (ko) 2003-05-09
CN1469740A (zh) 2004-01-21
US20030183091A1 (en) 2003-10-02
HK1059052A1 (en) 2004-06-18
AU9424501A (en) 2002-04-22
CA2425773A1 (en) 2003-04-11
EP1325743A4 (en) 2004-12-15
CN1278677C (zh) 2006-10-11
EP1325743A1 (en) 2003-07-09

Similar Documents

Publication Publication Date Title
PL368976A1 (en) Composition for lowering blood cholesterol
HK1034647A1 (en) Product and method to reduce stress induced immunesuppression.
AU2002256093A1 (en) Bulking agents as satiety agents
AR020345A1 (es) Pirazol-carboxanilidas, procedimiento para su obtencion, composiciones, empleo de dichos compuestos y procedimiento para la lucha contra microorganismos indeseables, y procedimiento para la obtencion de dichas composiciones.
SG150510A1 (en) Lipase activity inhibitors containing high-molecular weight polyphenol fractions, tea extracts, and processes for producing the same
EP1582207A4 (en) HEMMER FOR OUTBREAKING AND PROGREDIENCE OF LIVER CANCER
MY130670A (en) 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
CA2290072A1 (en) Citrus products incorporating pulp processing
HK1074592A1 (en) 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
WO2007022344A3 (en) Methods and compositions for the preventioin and treatment of kidney disease
GT199900035A (es) Producto de higiene personal con despacho aumentado de fragancia.
BG109876A (en) APPLICATION OF L-CARNITIN ESTERS OR ALCANAILIC L-CARNITINES AS CATIONARY LIPIDS FOR INTRACULAR TRANSMISSION OF PHARMACOLOGICALLY ACTIVE SUBSTANCES
AU4073901A (en) Novel pharmaceutical or dietetic mushroom-based compositions
EP0841065A3 (en) Use of sericin as antioxidants and tyrosinase inhibitors
WO1999066914A3 (en) Neuroprotective composition for the prevention and/or treatment of nervous and behavioural alterations due to anxiety states or depression, comprising acetyl-l-carnitine and hypericin
TW200626080A (en) Food compositions comprising valine for improving lipid metabolism
HK1083296A1 (en) Enteral composition for the prevention and/or treatment of sepsis
MX2007004879A (es) Proteccion de ingredientes de alimentos bioactivos por medio de encapsulacion.
MXPA04001129A (es) Mezclas de lipidos y productos de alimento que contienen acido graso oleico y acidos grasos omega-6, disenadas para incrementar el nivel intramiocelular de lipidos.
WO2000043036A3 (en) Lipoprotein complexes and compositions containing them
SI1708711T1 (sl) Spojine uporabne posebno za zdravljenje ali prepreäśevanje metaboliäśnega sindroma
MY130792A (en) 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES
WO2006093408A3 (en) Bacteria that naturally overproduce folate
WO2006089211A3 (en) Combat/training antioxidant micronutrient formulation and method of administration
AU2002222589A1 (en) Oral preprations having itching-relievign or antipruritic activity